September 2014 FDA Recall Bupivacaine Hydrochloride by Hospira Inc.
D-1588-2014 - Presence of Particulate Matter

This Class II drug recall was voluntarily initiated by Hospira Inc. on September 4, 2014 for the product Bupivacaine Hydrochloride. The FDA reported the reason for recall as presence of particulate matter. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1588-2014

Reason for Recall
Presence of Particulate Matter: A confirmed customer complaint reported the presence of a brown, rust-colored particle embedded at the bottom of the glass vial.
Initiated
09-04-2014
Reported
09-24-2014
Quantity
75,000 vials

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Bupivacaine HCl Inj., USP, 0.5% (5 mg/mL), 30 mL Single-dose Preservative-Free, For Nerve Block, Caudal, and Epidural Anesthesia, Not for Spinal Anesthesia, Rx Only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-1162-02

Batch or Lot Expiration Information

Lot# LOT 37-268-DK; Exp: 1JAN2016